HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.

Abstract
The association between maturity onset diabetes of the young (MODY) and type 1 diabetes mellitus (T1DM) has been rarely described. We report two patients affected by MODY who developed T1DM. Case 1: a 4-yr-old girl referred for glycosuria presented hemoglobin A1c (HbA1c) of 6.6%. Islet cell antibodies (ICA) and anti-glutamic acid decarboxylase (GADA) were initially negative. As her father, uncle and grandmother showed mild hyperglycemia, they were screened for MODY 2. A novel mutation in glucokinase gene was found in the family. Few months later, her glycemic control worsened consistently and she required insulin treatment. A high titer of GADA and ICA was then detected. Six years afterwards insulin requirement is 0.8 U/kg and HbA1c 6.7%. Case 2: a 15-yr-old boy treated for growth hormone deficiency was found with a blood glucose level of 106 mg/dL. HbA1c was 7.2%, ICA and GADA were negative. Family history was positive for autoimmune diseases and type 2 diabetes mellitus. The patient was investigated for MODY 2 and MODY 3, and a mutation of hepatocyte nuclear factor-1 alpha gene was found. The same mutation was found in the mother who had never been referred for hyperglycemia. After 1 yr, due to an unjustified worsening of the metabolic control, autoimmunity was again investigated and a mild positivity was found. He then required insulin therapy and after 5 yr current HbA1c was 8.2%. The diagnosis of MODY does not exclude the risk of developing T1DM. Therefore autoimmunity should be investigated when ordinary treatments fail and metabolic control unexpectedly worsens.
AuthorsGiulio Maltoni, Stefano Zucchini, Mirella Scipione, Vilma Mantovani, Silvana Salardi, Alessandro Cicognani
JournalPediatric diabetes (Pediatr Diabetes) Vol. 13 Issue 2 Pg. 208-12 (Mar 2012) ISSN: 1399-5448 [Electronic] Denmark
PMID21696527 (Publication Type: Case Reports, Journal Article)
Copyright© 2011 John Wiley & Sons A/S.
Chemical References
  • Autoantibodies
  • Glycated Hemoglobin A
  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human
  • islet cell antibody
  • Glucokinase
  • Glutamate Decarboxylase
Topics
  • Adolescent
  • Age of Onset
  • Autoantibodies (blood, immunology)
  • Child, Preschool
  • Diabetes Mellitus, Type 1 (diagnosis, drug therapy, genetics)
  • Diabetes Mellitus, Type 2 (diagnosis, drug therapy, genetics)
  • Female
  • Glucokinase (genetics)
  • Glutamate Decarboxylase (immunology)
  • Glycated Hemoglobin (analysis)
  • Hepatocyte Nuclear Factor 1-alpha (genetics)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Insulin (therapeutic use)
  • Male
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: